Veszpremi Ervin 4
4 · Kindred Biosciences, Inc. · Filed Jan 24, 2018
Insider Transaction Report
Form 4
Veszpremi Ervin
Director
Transactions
- Award
Stock Option (right to buy)
[F1]2018-01-22+75,000→ 75,000 totalExercise: $8.75Exp: 2028-01-22→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The option will vest as to 25% quarterly following the date of grant.
Signature
/s/ Dietrick Miller, Attorney in Fact|2018-01-24